Related Experiment Videos
St John's wort for the treatment of depression
1Department of Psychiatry, Vanderbilt University School of Medicine, Nashville, TN, USA. richard.shelton@mcmail.vanderbilt.edu
The Lancet. Neurology
|July 10, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Silent regulators of trauma: the microRNA blueprint underlying post-traumatic stress disorder biology.
Environmental epigenetics·2026
A novel sequential ketamine and D-cycloserine/lurasidone therapy for bipolar depression with acute suicidal ideation.
Expert opinion on investigational drugs·2026
Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD).
International clinical psychopharmacology·2026
Psilocybin in the Treatment of Cocaine Use Disorder: A Randomized Clinical Trial.
JAMA network open·2026
The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensus.
The British journal of psychiatry : the journal of mental science·2026
Cholinesterase inhibitors in people with dementia with Lewy bodies and cardiac conduction abnormalities.
The Lancet. Neurology·2026
Advances in chronic subdural haematoma management: beyond the burr hole.
The Lancet. Neurology·2026